Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...

Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...

Up to 11% of infants are born with a condition called tongue-tie where the small band of tissue under the tongue is too short, thick, or tight, limiting the tongue's mobility and preventing proper ...

Discover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...

WIT Legal ("WIT"), the leading agency representing testifying experts for high-stakes, complex legal matters, today released their annual report evaluating Hatch-Waxman litigation. The report, 2024 in ...

The latest terms include $3.05 billion in cash – including $100 million to the tribes – and $1.2 billion of Teva's generic of Opiant's opioid overdose reversal agent Narcan (naloxone ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of ...

to the use of a decongestant alone (xylometazoline hydrochloride 0.05% nasal spray) or to a placebo (normal saline solution) before performing a flexible nasal endoscopy. This study showed no ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Bonus May 05, 1995 Jun 01, 1995 Feb 16, 1995 Bonus Ratio: 1 share(s) for every 2 shares held Rights Aug 07, 1992 Sep 01, 1992 Sep 30, 1992 Rights ratio: 1 share for every 1 held at a price of Rs 60.0 ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities ...